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O-glycansMimicking the biochemical reactions that take place in cell organelles is becoming one of the most important
challenges in biological chemistry. In particular, reproducing the Golgi glycosylation system in vitro would
allow the synthesis of bioactive glycan polymers and glycoconjugates for many future applications including
treatments of numerous pathologies. In the present study, we reconstituted a membrane system enriched in
glycosyltransferases obtained by combining the properties of the wheat germ lectin with the dialysable
detergent n-octylglucoside. When applied to cells engineered to express the O-glycan branching enzyme
core2 beta (1,6)-N-acetylglucosaminyltransferase (C2GnT-I), this combination led to the reconstitution of
lipid vesicles exhibiting an enzyme activity 11 times higher than that found in microsomal membranes. The
enzyme also showed a slightly higher afﬁnity than its soluble counterpart toward the acceptor substrate.
Moreover, the use of either the detergent re-solubilization, glycoprotein substrates or N-glycanase digestion
suggests that most of the reconstituted glycosyltransferases have their catalytic domains in an extravesicular
orientation. Using the disaccharide substrate Galβ1-3GalNAc-O-p-nitrophenyl as a primer, we performed
sequential glycosylation reactions and compared the recovered oligosaccharides to those synthesized by
cultured parental cells. After three successive glycosylation reactions using a single batch of the reconstituted
vesicles and without changing the buffer, the acceptor was transformed into an O-glycan with
chromatographic properties similar to glycans produced by C2GnT-I-expressing cells. Therefore, this new
and efﬁcient approach would greatly improve the synthesis of bioactive carbohydrates and glycoconjugates in
vitro and could be easily adapted for the study of other reactions naturally occurring in the Golgi apparatus
such as N-glycosylation or sulfation.embrane system; WGA, wheat
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Mucin type O-glycans involving the GalNAc-(Thr/Ser)peptide
backbone play critical roles in widespread physiopathological mech-
anisms such as cell signaling and apoptosis, cell adhesion and
migration, endocytosis and microbe–host cell interaction [1–5].
Among O-glycans, those having core2 branches are key structures in
forming sialyl-Lewis x (sLex) and/or MECA-79 epitopes on selectin
ligands [6–8]. The latters are important regulators of the immune
response and therefore, they represent potential drug targets for thetreatment of inﬂammatory disorders and other pathologies involving
selectins [9]. One approach to treat these diseases is to disrupt
carbohydrate-mediated cell adhesion processes using sLex andMECA-
79 ligand-mimetic oligosaccharides. Therefore, it is necessary to
develop efﬁcient methods for the synthesis of these compounds either
free or linked to proteins or lipids.
Branched O-glycans are synthesized in the Golgi apparatus and are
dependent on the presence of the enzyme core2 beta (1,6)-N-
acetylglucosaminyltransferase (C2GnT-I), the expression of which is
highly regulated in the cell [7]. Once the core2 branch is initiated, it is
followed by at least three successive transfer reactions involving β(1,4)-
galactosyltransferases,α(2,3)-sialyltransferases andα(1,3)-fucosyltrans-
ferases [10]. These enzymes, like other Golgi glycosyltransferases, are
type-II membrane glycoproteins with a C-terminal catalytic domain
oriented to the lumenof theGolgi stacks inorder to catalyze carbohydrate
transfer from sugar nucleotide donors to substrate acceptors.
Glycan polymers, as opposed to proteins and DNAs, are synthe-
sized without a template. Instead, the sugar sequence is dependent on
the ability of glycosyltransferases to encounter both their cognate
acceptor substrates, made in the same or earlier compartments, and
the corresponding nucleotide sugar donors, which are translocated
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compartmentalized in a way that sugar residues are added in the
same order as their corresponding glycosyltransferases are distribut-
ed throughout the Golgi stacks [11].
Branched complex oligosaccharides can be synthesized using
puriﬁed Golgi fractions or cells transfected with the appropriate
glycosyltransferase genes, and then permeabilized to allow exogenous
saccharide primers to diffuse across themembranes [12]. However, this
approach is time consuming and not easily adaptable to quantitative
production of oligosaccharides. The synthesis of glycans in general
and O-glycans in particular can also be achieved chemically, but the
polyhydroxyl nature of carbohydrates makes it difﬁcult to modify a
hydroxyl group without affecting the others [13]. Besides, these
approaches are laborious and require the use of toxic reagents for the
protection–deprotection reactions, which represents serious hazards
for the individuals and for the environment. O-linked oligosaccharides
can also be built-up enzymatically or chemoenzymatically but the
difﬁculty of obtaining pure and stable natural or recombinant enzymes,
together with the frequently encountered buffer incompatibilities,
greatly hampers their use in large scale preparations [14,15].
These restrictions together with the low yield of Golgi proteins
recovered after lengthy puriﬁcation protocols led us to search for a
simpler method to prepare a glycosylation machinery that would
allow the synthesis of oligosaccharides resembling natural molecules.
For this purpose, we isolated Golgi-resident glycoproteins bymeans of
the wheat germ lectin WGA which is known to react with Golgi and
plasma membrane components and which has long been considered
as a tool to stain the Golgi apparatus [16]. This property added to
the tendency of this lectin to form homodimers in solution [17]
prompted us to use it in combination with the dialysable detergent
n-ctylglucoside [18], to selectively precipitate solubilized plasma
membrane and Golgi components. The removal of both the detergent
and the lectin yielded a precipitate that we further identiﬁed as
lipid vesicles enriched in several active glycosyltransferases of the
O-glycosylation pathway.
2. Materials and methods
2.1. Materials and reagents
Asialofetuin, CMP-NeuAc, UDP-Gal, UDP-GlcNAc,WGA, TRITC-WGA,
tri-N-acetyl-chitotriose, GlcNAc, phospholipid and cholesterol stan-
dards were purchased from Sigma-Aldrich. UDP-[6-3H]GlcNAc (35 Ci/
mmol) was from PerkinElmer (PerkinElmer Science Inc., Boston) and
the synthetic acceptor substrate Galβ1-3GalNAc-O-p-nitrophenyl was
purchased from Toronto Research Chemicals (North York, Ontario,
Canada). The expression vector pSecTagwas from Invitrogen (Carlsbad,
CA). Restriction enzymes and Taq polymerase were from Promega and
n-octyl-β-D-glucopyranoside (n-octylglucoside, OG), PNGase-F and
EDTA-free protease inhibitor cocktail were from Roche Pharma
(Strasbourg, France). Cell dissociation buffer, culture reagents and
Lipofectamine 2000 were from Invitrogen.
2.2. Cells, DNAs and transfection
CHO cells were cultured in Ham-F12medium containing 10% (v/v)
fetal calf serum, antibiotics and appropriate drugs used for their
selection. Cells expressing C2GnT-I-EGFP (CHO/C2GnT-I-EGFP) have
been described in a previous work [19]. In order to allow the secretion
of soluble C2GnT-I, the catalytic domain of the enzyme (encoding
protein sequence from amino acid 33–395) was ampliﬁed by PCR and
subcloned into the pSecTag expression vector in-frame with the
leader sequence and followed by the myc (EQKLISEEDL) and (His)6
sequences, for expression as solC2GnT-I-myc-(His)6 (where sol
stands for soluble form of the enzyme). CHO cells stably expressing
solC2GnT-I-myc-(His)6 were prepared by transfecting semiconﬂuentCHO-K1 cells with 1 μg DNA of pSegTag/solC2GnT-I DNA using
Lipofectamine 2000 procedure as recommended by the manufacturer.
After 2–3 weeks in the presence of 500 μg/ml zeocin, resistant
transfectants were collected using cloning cylinders and positive
secreting clones were identiﬁed by dot-blotting using either the anti-
C2GnT-I polyclonal antibody 1719.39 [20] or the 9E10 anti-myc
antibody. Alcaline phosphatase-conjugated second antibodies were
then used to detect the secreted proteins.
2.3. Soluble and membrane-associated glycosyltransferases preparation
Cells permanently expressing solC2GnT-I-myc-(His)6 (referred to as
solC2GnT-I throughout this study)were cultured in low-serummedium
(2% fetal calf serum) and media were collected every other day, cleared
off detached cells and debris by centrifugation at 1000 rpm for 5 min,
ﬁltered through a 0.22-μm pore-size ﬁlters and concentrated 10 times
by ultraﬁltration using Microcon YM-10 concentrator (Millipore,
Molsheim, France). For solubilization and membrane reconstitution,
cells expressing C2GnT-I-EGFP were harvested in the cell dissociation
buffer and rinsed twice in PBS before solubilization. The cell pellet was
then resuspended in 1% n-octyl-β-D-glucopyranoside in HMG buffer
(20 mMHepes, pH7.4, containing EDTA-freeprotease inhibitor cocktail,
1 mMMgCl2, 10%glycerol). Themixturewas incubatedon ice for 20 min
under agitation and then centrifuged at 100,000g for 30 min in a
Beckmann ultracentrifuge (Optima LE-80 K ultracentrifuge, rotor 42.1
Ti). The pellet was discarded and the clear supernatant (OG extract) was
supplementedwith 1 mg/ml ofWGAand further incubated for 30 min at
4 °C, after which the clear OG extract turned to turbid. A yellowish pellet
(WGA pellet) was obtained after another centrifugation at 100,000g for
30 min and rinsed twice by centrifugation in detergent-free HMG buffer
to remove traces of OG. In order to dissociate WGA from aggregates, the
pellet was resuspended in detergent-free HMG buffer containing the
lectin competing saccharide tri-N-acetylchitotriose (3 mM) and homog-
enized by passing the suspension through a 25-gauge needle. A white
translucent pellet was obtained after another round of centrifugation
(100,000g for 30 min), washed twice in detergent-free HMG buffer
containing 100 mMN-acetylglucosamine to remove traces of WGA,
resuspended in the same buffer and stored at −20 °C until use. This
preparationwas found to be enriched in glycosyltransferases and for this
reason was named GEMS (Glycosyltransferase-Enriched Membrane
System).
2.4. Lipid analysis
Lipids were extracted from samples with a chloroform/methanol
solvent (9/1, v/v) and chromatographed on a silica gel TLC plate (Merck,
Darmstadt, Germany) in chloroform/methanol/acetic acid/water
(50/30/8/3, v/v). The TLC plate was then dried and chromatographed
again in heptane/diethyl ether/acetic acid solvent (70/30/2, v/v) and
lipid spots were visualized using 0.2% (w/v) amido black in 1 MNaCl as
described [21].
2.5. In vitro enzyme assays
The C2GnT-I activity was assayed essentially as previously de-
scribed [22], using the oligosaccharideGalβ1-3GalNAc-O-p-nitrophenyl
as an acceptor and UDP-GlcNAc as a donor. Standard reactions
were conducted at 37 °C for 60 min in 50 mM MES buffer pH 7
containing 50–60 μg/ml of GEMS preparation, 1 mM UDP-GlcNAc,
0.5 μCi UDP-[6-3H]GlcNAc and 1 mM acceptor in a total volume of
50 μl. The reaction was stopped by addition of 5 ml water and the
mixture was applied to a Sep-Pak C18 reverse-phase chromatogra-
phy cartridge (Waters, Milford, Massachusetts). After washing with
20 ml of water, the radiolabeled product was eluted with 2 ml of
methanol, 500 μl of which were counted after addition of 3 ml of the
counting scintillant liquid PCS (Amersham, Buckinghamshire,
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GlcNAc transferred per minute (enzyme unit, U) and per milligram
of protein. Measurements were performed in duplicates and
repeated at least 3 times. Background radioactivity was determined
under identical conditions except that the acceptor was omitted in
the reactions. The Km value for the acceptor was determined under
standard conditions using a range of concentrations between 0.1 and
5 mM acceptor substrate. In some instances, microsomes were
prepared from CHO/C2GnT-I-EGFP cells according to Jamieson and
Palade [23] and their C2GnT-I activity was compared to that of the
GEMS-associated enzyme. The α(1,2)-fucosyltransferase (FucT-I,
α2FT) and sialytransferases activities associated to GEMS material
were assayed as described previously [19] except that asialofetuin
(2.5 mg/ml ﬁnal concentration) was used as an acceptor instead of
the synthetic oligosaccharide. These activities were assayed in the
presence of either GDP-[14C]fucose for α2FT or CMP-[3H]sialic acid
for α(2,3)- and α(2,6)-sialyltransferases (α3/6ST) activities. The
protein substratewas then precipitatedwith 10% trichloroacetic acid
in cold acetone and counted.
Sequential glycosylation reactions were carried out in the presence
of GEMS preparation (400–450 10−6 U/mg) in 50 mMMES buffer pH
6.8 containing EDTA-free protease inhibitor cocktail. The reaction was
initiated by adding 1 mM UDP-GlcNAc, 2 μCi UDP-[6-3H]GlcNAc and
5 mMGalβ1-3GalNAc-O-p-nitrophenyl in a volume of 80 μl. Following
1 h incubation at 37 °C, 10 μl of UDP-galactose and MnCl2 in water
were added to the mixture to yield a ﬁnal concentration of 1 mM
and 10 mM, respectively. Then the reaction was continued for an
additional 30 min at 37 °C. The last reaction of sialylation was
performed for 30 min at 37 °C after adding 10 μl water containing
CMP-sialic acid to yield a ﬁnal concentration of 100 μM in a total
volume of 100 μl. The reaction was stopped by adding 5 ml of 250 mM
ammonium formate buffer (pH 4) and applied to Sep-Pak C18
cartridges. Columns were then rinsed with 20 ml of ammonium
formate buffer and bound labeled acceptors were eluted with 70%
(v/v) methanol/water, counted and analyzed as below.2.6. Analysis of O-glycans isolated from cells or prepared using GEMS
material
The parental CHO-K1 and CHO/C2GnT-I-EGFP cells were seeded in
15 cm dishes and cultured until they reached 80% conﬂuency. They
were then metabolically labeled with [3H]glucosamine (10 μCi/ml)
and O-glycans were extracted and analyzed as described [20]. Brieﬂy,
following the 24 h incubation with [3H]glucosamine, cells were
detached by the non-enzymatic cell dissociation solution and
sedimented. The pellets were resuspended in PBS buffer containing
1% NP40 and subjected to pronase digestion as described [24]. The
glycopeptides obtained were applied to a Sephadex G-50 (superﬁne)
column (1 cm × 110 cm) equilibrated with 0.1 M NH4HCO3. Higher
molecular weight species recovered in the void volume were
lyophilized and treatedwith alkaline borohydride to releaseO-glycans
(β-elimination) as described [24] and the released O-glycans were
separated from the remaining material using the same Sephadex
G-50 gel ﬁltration. The obtained O-glycans were analyzed by Bio-Gel
P-4 gel ﬁltration using the same conditions as described [20]. The
columnwas calibrated with the oligosaccharide standards presented
in Fig. 7 (kindly provided by Pr M Fukuda, The burnham Institute,
La Jolla). The analysis of the oligosaccharides synthesized using
GEMS preparation was performed essentially as above except that
the Sep-Pak eluted fraction (15000 cpm) was dried in vacuo on a
SpeedVac concentrator (GMI Inc. USA) treated with alkaline
borohydride and fractionated on the Bio-Gel P-4 column calibrated
as above. Mild acidic treatment to remove sialic acid from O-glycans
was performed by incubating lyophilized samples in 0.1 M HCl at
80 °C for 1 h [25].2.7. Fluorescence and electron microscopy
Confocal microscopy was used to compare the intracellular
distribution of EGFP-tagged glycosyltransferases (C2GnT-I) with
that of rhodamine-labeled WGA essentially as previously described
[26]. For electron microscopic analyses, the GEMS preparation was
ﬁxed with 2% glutaraldehyde in 0.1 M phosphate buffer pH 7.4,
postﬁxed with 1% osmium tetroxide, dehydrated through cold graded
ethanol and embedded in Epon. The sections were then examined
with a Jeol 100C microscope. For negative staining and electron
microscopy, GEMS samples (20 μl) were loaded onto paraﬁlm and
formwar coated grids were applied onto for 3 min at 4 °C. Excess
solution was removed by quickly blotting grids with ﬁlter paper.
Negative staining procedure was performed with phosphotungstic
acid diluted to 1% in distilled water and grids were examined using a
Zeiss electron microscope EM 912. Dimensions of the vesicles were
determined from negative staining and thin sectionmicrographs as an
average between the maximal diameter of the largest proﬁle, in the
longitudinal direction and in a direction perpendicular to it.
2.8. PNGase-F (N-glycanase) treatment
PNGase-F treatment was performed essentially as previously
described [19]. Brieﬂy, GEMS fractions (20 μg protein) were resus-
pended in 100 mM Tris/HCl buffer pH 8.6 containing EDTA-free
protease inhibitor cocktail, either in the absence (native conditions)
or the presence of 1% Triton X-100 and 1% β-mercaptoethanol
(denaturing conditions). PNGase-F (80 U/mgs/ml) was then added to
the samples and incubation was carried out for 1 h at 37 °C. Control
samples did not receive the enzyme. Proteins were then separated by
SDS/PAGE as below.
2.9. SDS/PAGE and Western immunoblotting
Protein concentration was determined with the bicinchoninic acid
(BCA) protein quantiﬁcation kit (Sigma) using bovine serum albumin
as a standard. Proteins (20 μg/sample) were resolved on a 10% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis gel according to
Laemmli [27]. After electrophoresis, proteins were transferred to
nitrocellulose membranes, blocked for 1 h in Tris-buffered saline
(TBS) containing 3% BSA. Membranes were probed with either the
anti-Core2 polyclonal antibody as described [26] or the anti-EGFP
mAb JL-8 as described [28], followed by peroxidase-conjugated
secondary antibodies and visualization of bands was achieved by
chemiluminescence using the ECL kit (Amersham Pharmacia Biotech,
Buckinghamshire, United Kingdom).
3. Results
3.1. The Golgi apparatus including the C2GnT-I compartment strongly
reacts with WGA
The Golgi apparatus is considered as a reservoir for many
glycosyltransferases including those involved in the O-glycosylation
pathways [29]. The wheat germ lectin (WGA) is known as a mean to
stain the Golgi stacks [16], presumably through interactions with
sialo-glycoconjugates that are concentrated in this organelle [17]. By
using the C2GnT-I as a cis to medial/Golgi-resident enzyme model
[26], we ﬁrst aimed to check whether this compartment is actually
stained by WGA. As shown by confocal laser scanning microscopy in
Fig. 1A, the incubation of permeabilized CHO/C2GnT-I-EGFP cells
(green) with RITC-WGA led to a strong staining of the Golgi apparatus
(red) including the C2GnT-I compartment. A faint cell surface staining
with the lectin can also be seen (merge). This result conﬁrms that
WGA interacts with the Golgi apparatus and establishes that the Golgi
and plasma membranes are the major cell structures recognized by
Fig. 1. Fluorescent and electronic microscopic examinations. A) Confocal ﬂuorescent micrographs showing the intracellular distribution of the C2GnT-I-EGFP and RITC-conjugated
WGA (RITC-WGA). CHO/C2GnT-I-EGFP cells were ﬁxed in PBS containing 4% (w/v) paraformaldehyde and permeabilized in the presence of 0.5% (v/v) Triton X100 and 1% (v/v) fetal
calf serum. They were then stained with RITC-WGA and examined by confocal microscopy. The merged images show overlapping red and green pixels in yellow (merge).
Magniﬁcation: 500×. B) Electron microscopic images of negatively stained GEMS preparation (left) and thin section electron microscopy of a GEMS sample (right). The micrographs
show representative results of at least three different independent experiments. Scale bar, 200 nm.
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form homodimers in solution [17] prompted us to isolate the WGA-
reactive Golgi components from the detergent extract of CHO/C2GnT-
I-EGFP cells. For this purpose, we choose the non-ionic detergent
n-octylglucoside (OG) which is known to be easily removed [18] and
also to only partially delipidate solubilized membrane proteins [30].
Thus, after stepwise elimination of both the detergent and the lectin
(see Materials and methods for details), we obtained a sedimentable
material that we examined by electron microscopy. As shown in
Fig. 1B, electron microscopic examination of thin sections of this
material or after negative staining revealed the presence of vesicles
having shapes of sealed membranes with varying diameters from
approximately 20–80 nm. These results show that solubilizing cells
with OG followed by glycoprotein precipitation with WGA yielded a
material composed of membrane vesicles presumably formed from
endogenous lipids. Other detergents such as Tween 20, Triton X-100
or CHAPSwere either inefﬁcient or could solubilize active C2GnT-I to a
certain extent but OG was by far the most effective with respect to
vesicle formation and enzyme functionality (Table 1).
To conﬁrm the presence of lipids in this material, we analyzed its
lipid content and compared it to a crude membrane preparation and
microsomes. As shown in Fig. 2A, phosphatidylcholine (PC), phos-
phatidylserine (PS), sphingomyelin (SM) and cholesterol (Chol)
originally present in membranes were recovered in the reconstituted
material. Other components (nd) as well as phosphatidylethanol-
amine (PE), which partially overlaps with PC in our chromatographicsystem, could also be part of these phospholipids. Likewise, the
protein pattern of GEMS is comparable to that of crude membranes or
microsomes (Fig. 2B), indicating that sphingomyelin, phospholipids
and cholesterol are co-precipitated with membrane glycoproteins.
Consistent with previous studies on OG-mediated solubilization by
Helenius and co-workers [30], this result suggests that lipids remain
attached to the hydrophobic domains of membrane proteins during
solubilization. Thus, following the removal of the detergent and the
lectin, the transmembrane domains may become spontaneously
incorporated into lipid vesicles. Based on these facts and others to
be presented below, this material was named Glycosyltransferase-
Enriched Reconstituted Membrane System, GEMS.
3.2. The recovery of C2GnT-I in GEMS preparation
In order to evaluate the efﬁciency of C2GnT-I recovery in this
preparation, the presence of the enzyme in different fractions was
checked by Western blotting using the anti-C2GnT-I polyclonal
antibody. As shown in Fig. 3A, the 75–80 kDa protein species
corresponding to the chimericmolecule C2GnT-I-EGFP [19] is efﬁciently
solubilized (compare lanes Lysate and OG extract), precipitated by
the lectin (lane WGA pellet) and recovered in the ﬁnal pellet (lane
GEMS). This result indicates that this procedure allows a signiﬁcant
recovery of C2GnT-I.
The Golgi glycosyltransferases are membrane-anchored glycosyl-
ated proteins [19], which provides an explanation for their interaction
Table 1
Comparison of detergent efﬁciency with respect to solubilization and reconstitution of
the C2GnT-I activity. Shown is a compilations of results from at least three independent
experiments. nd: not determined.
Detergent Solubilized C2GnT-I
activity
WGA
pellet
Reconstituted
C2GnT-I activity
OG +++ +++ +++
Tween 20 None nd nd
CHAPS ++ +++ ++
Triton X-100 +++ ++ ++
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of both the lectin and the detergent. Yet, one cannot exclude the
possibility that membranous but non-glycosylated proteins could co-
precipitate with WGA thereby remaining associated with GEMS
material. To address this question,we took advantage from the chimeric
protein C2[1–32]-EGFP, comprising the cytosolic and transmembrane
domain of C2GnT-I (from the ﬁrst methionine to the amino acid 32)
fused to EGFP. We have previously shown that this is targeted to the
same Golgi compartment as the intact enzyme [26]. Since EGFP is not
glycosylated [31], we postulated that this protein should not precipitate
withWGAdespite its localization in theGolgi. In fact, as shown inFig. 3B,
the C2[1–32]-EGFP, present in the total cell lysate (lane Lysate) as a 26
kDa species and in the detergent extract (lane OG extract), is not
precipitatedbyWGA(laneWGA)andnot recovered in the reconstituted
membranes (laneGEMS). Taken as awhole, the above data indicate that
C2GnT-I and presumably other resident Golgi glycosyltransferases are
precipitated by WGA through speciﬁc glycan-mediated interactions to
be further integrated into the reconstituted membranes.3.3. Functionality of the reconstituted glycosyltransferases
The results presented above clearly argue for a membrane-
incorporated state of glycosyltransferases in the GEMS preparation.Fig. 2. Lipid and protein analyses of GEMSmaterial. A)Microsomeswere prepared fromCHO/C
the samehomogenate as a 25,000gpellet of thepost-nuclear fraction. Lipids fromthese samples
gel plate in chloroform/methanol/acetic acid/water (50/30/8/3, v/v), dried and chromatogra
visualized using 0.2% (w/v) amido black in 1 M. Reference lipid markers are indicated on t
phosphatidylserine, sphingomyelin and cholesterol, respectively. nd, non-identiﬁed lipids. B) Co
GEMS. Protein electrophoresis was performed as described inMaterials andmethods except tha
Blue in 7.5% acetic acid and 50% ethanol.Yet, reconstituting integral enzymes into membrane vesicles often
led to a decrease in enzymatic activity mainly due to new microenvi-
ronment [32,33]. By choosing the C2GnT-I as a model, we wanted to
know whether the GEMS-associated enzyme is functionally recon-
stituted and how this activity is enriched, with respect to the total
cell lysate and microsomes derived from the same cells. As shown in
Fig. 3D, the speciﬁc activity of GEMS-associated C2GnT-I (216±16
10−6 U/mg) is about 4 times higher than in the crude cell lysate
(69±8 10−6 U/mg), indicating that a signiﬁcant activity enrichment
occurs upon reconstitution. This increased activity could be related to
the integrated state of the protein in GEMS versus the soluble form of
enzyme in the detergent extract. To explore this possibility, we
compared the GEMS-associated C2GnT-I to its recombinant soluble
form (solC2GnT-I) with respect to their Km values toward the acceptor
substrate. We found Km values of 0.72±0.23 mM and 0.35±0.08 mM
for the solC2GnT-I and the GEMS-associated enzyme, respectively.
Thus the membranous enzyme exhibits a comparable or slightly
better afﬁnity for the acceptor than its soluble counterpart. It is
therefore likely that the membrane environment exerts a positive
inﬂuence on the catalytic activity of the enzyme, presumably through
endogenous lipids. A similar observation has been reported for the
α(2,6)-sialyltransferase-I [34].
If that is the case, then the speciﬁc activity of C2GnT-I in GEMS
should not be signiﬁcantly different from that of intact membranes
such as microsomes. Microsomes are a mixture of membranes [35]
prepared by differential centrifugation from which Golgi membranes
can be puriﬁed by additional centrifugation steps [35,36]. Based on
their heterogeneity, microsomes could be considered as a crude
preparation of Golgi components, just like our GEMS material. As
shown in Fig. 3C, the isolated microsomes contain a signiﬁcant
amount of the C2GnT-I-EGFP protein, as compared to GEMS. As
shown in Fig. 3E, the C2GnT-I activity in the microsomes is about 11
times weaker (19±3 10−6 U/mg) than in GEMS preparation (216±
16 10−6 U/mg). This result is in agreement with ﬁndings from Freeze's
group who showed that Golgi membranes puriﬁed from C2GnT-I-2GnT-I-EGFP according to [23] and crudemembranes (CrudeMemb.) were prepared from
were then isolated and compared to those ofGEMS. Theywere chromatographedona silica
phed again in heptane/diethyl ether/acetic acid solvent (70/30/2, v/v). Lipid spots were
he right. PC, PE, PS and SM and Chol, phosphatidylcholine, phosphatidylethanolamine,
mparison of protein patterns between crudemembranes (CrudeMemb.),microsomes and
t a 7.5% SDS/PAGEwas used. After electrophoresis, gels were stainedwith 0.2% Coomassie
Fig. 3. C2GnT-I recovery and activity in GEMS and microsomes. A) and B) Immunoblots of C2GnT-I and C2[1–32]-EGFP in different fractions of the reconstitution process. Cells
expressing C2GnT-I-EGFP (A) or C2[1–32]-EGFP (B) were solubilized in OG (lane Lysate). The detergent extracted glycoproteins (lane OG extract) were then precipitated by WGA
(laneWGA pellet) and the GEMSmaterial was obtained after the addition of the tri-N-acetylchitotriose competing saccharide (lane GEMS). Samples (20 μg protein) were resolved on
10% SDS/PAGE and transferred to nitrocellulose. Proteins were then detected either with the anti-C2GnT-I polyclonal antibody (A) or the anti-EGFP mAb JL-8 (B). C) Immunoblot of
the C2GnT-I in GEMS and microsomes prepared from CHO/C2GnT-I-EGFP. The protein was detected with the anti-C2GnT-I polyclonal antibody. Reference protein size markers are
indicated on the left of the ﬁgures. E) and D) Comparison of C2GnT-I activity in lysates and GEMS preparations (D) and between microsomes and GEMS fractions (E). The C2GnT-I
activity was assayed as described under Materials and methods using the oligosaccharide Galβ1-3GalNAc-O-p-nitrophenyl as an acceptor and UDP-GlcNAc as a donor. Speciﬁc
activity (in U/mg) was calculated as micromoles of GlcNAc transferred per milligram of protein and per minute. Data represent mean±SE from three independent experiments
performed in duplicate determinations.
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dependent structures [12].
3.4. Orientation of glycosyltransferases in GEMS vesicles
A random asymmetric orientation of membrane-anchored
enzymes is often obtained upon reconstitution, leading to a mixture
of rightside-out (i.e., catalytic domains in an extravesicular orienta-
tion) and rightside-in, which may dramatically inﬂuence enzyme
accessibility [37]. In fact, regarding the C2GnT-I activity, one could
assume that a small hydrophobic molecule such as Galβ1-3GalNAc-O-
p-nitrophenyl could easily diffuse across membranes and access the
catalytic domain regardless of the enzyme topology. Therefore, two
approaches were selected to address this issue: i) GEMS vesicles were
treated by PNGase-F which cleaves N-linked glycans including those
of C2GnT-I [28] and ii) we used a protein substrate (asialofetuin)
instead of the disaccharide acceptor.
Regarding theﬁrst issue,wehavepreviously shown that the catalytic
domain of C2GnT-I carries two N-linked oligosaccharide chains that can
be cleavedbyPNGase-F, leading to shift in themolecularweight of about
5 kDa [28].We therefore assumed that if the enzymehad a rightside-out
orientation, then its N-glycans should be accessible to the glycanase
[38]. Hence, the yield of de-N-glycosylation would provide indications
about the proportion of the enzyme with an extravesicular exposition.
As shown in Fig. 4A, a complete de-N-glycosylation of C2GnT-I is
obtained under denaturing conditions, consistent with our previousdata [28]. Under native conditions, a signiﬁcant de-N-glycosylation is
also observed, although the shift in this case is not as important as under
the denaturing conditions. This difference could be due to either an
incomplete de-N-glycosylation or to the presence ofβ-mercaptoethanol
(denaturing conditions), which may inﬂuence the protein behaviour in
SDS/PAGE. Of note, the faint smear left at the initial position of the
C2GnT-I-EGFP under the native conditions suggests that a small
proportion of the glycoprotein may not be accessible to PNGase-F.
Regarding the second issue, we reasoned that the hydrophility
and the size of asialofetuin (about 55–65 kDa) [39] would not allow
it to cross the lipid barrier of GEMS vesicles. Besides, the unmasked
galactose of this glycoprotein is available for receiving different
sugar residues from at least 3 different transferases including
α(2,3)- and α(2,6)-sialyltransferases (α3ST and α6ST) as well as
α(1,2)-fucosyltransferase-I (FucT-I, α2 FT). By doing so, we also
explore the accessibility and activities of other GEMS-associated
glycosyltransferases. For this purpose, GEMS fractions were pre-
pared from CHO cells expressing either α6ST or α2FT, both
enzymes being fused to EGFP [19,26,40]. As shown in Fig. 4B and
as anticipated, both glycosyltransferases are well recovered in
the GEMS material. Samples of these fractions were then assayed
for α(1,2)-fucosyl- or α(2,3/6)-sialyltransferase activities using
asialofetuin as an acceptor. As shown in Fig. 4C, the speciﬁc activity
of GEMS-associated α2FT (3.52±0.29 10−6 U/mg) is about 5 times
higher than in the crude cell lysate (0.67±0.19 10−6 U/mg), which
is in line with data from C2GnT-I (compare with Fig. 2D). The same
Fig. 4. Exploring the orientation of GEMS-associated glycosylransferases: A) Effects of de-N-glycosylation on C2GnT-I structure. GEMS fractions (adjusted to 20 μg protein) were
resuspended in 100 mM Tris/HCl buffer pH 8.6 containing EDTA-free protease inhibitor cocktail either in the presence of 1% Triton X-100 and 1% β-mercaptoethanol (denaturing
conditions) or in the absence of these reagents (native conditions). PNGase-F (80 units/ml) was then added (+) to the samples and incubation was carried out for 1 h at 37 °C. Control
samples did not receive the enzyme (−). Proteins were then separated on 10% SDS/PAGE. After electrophoresis proteins were transferred to nitrocellulose and the C2GnT-I-EGFP was
detectedwith the anti-C2GnT-I polyclonal antibody as above. Protein sizemarkers are indicated on the left of the ﬁgure. B) Immunoblots ofα2 FT andα6 ST from the lysate and GEMS
preparations. Cells expressing FUT1-EGFP (α2 FT) or ST6Gal-I-EGFP (α6 ST) were solubilized and GEMS material was obtained as in Fig. 3. C) Comparison of α2 FT and α3/6 ST
activities in lysates and GEMS preparations. Enzyme activities were assayed, as described in Materials and methods, using the asialofetuin (2.5 mg/ml) as an acceptor and either
GDP-fucose (α2FT activity) or CMP-NeuAc (α3/6ST activity) as donors. Theα3/6ST represents the sialylation activity of both endogenousα(2,3)-sialyltransferases (α3 ST), naturally
present in CHO cells, and the transfected α(2,6)-sialyltransferase-I-EGFP (α6ST). The speciﬁc activity (in U/mg) was calculated as micromoles of fucose or sialic acid transferred per
milligram of protein and per minute. Data represent mean±SE from three independent experiments performed in duplicate determinations.
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times increase (18.3±2.62 10−6 U/mg), compared to the total cell
lysate (4.6±0.28 10−6 U/mg). It is noteworthy that this measured
sialylation activity actually represents both endogenous α(2,3)-
sialyltransferases (α3ST), naturally present in CHO cells, and the
transfected α(2,6)-sialyltransferase (α6ST). These results clearly
argue for accessible catalytic domains of GEMS-associated
glycosyltransferases.
Aiming at preparing the core2-based sialyl-Lewis x oligosaccha-
ride, we assayed the α(1,3)-fucosyltransferase-VII (FucT-VII) activ-
ity in GEMS vesicles derived from CHO/FucT-VII-EGFP cells [19]. The
FucT-VII fucosylates the sialyllactosamine backbone on the GlcNAc
residue and requires the presence ofα(2,3)-linked sialic acid prior to
fucosylation [41]. Therefore, as an acceptor substrate, we used either
the sialylated glycoprotein fetuin or the disialotetrasaccharide that
we synthesized as detailed below. Unexpectedly, we could not detect
α(1,3)-fucosylation with neither the ﬁrst nor the second substrate
(data not shown). Given that FucT-VII is glycosylated [28] and should
therefore be precipitated by WGA, this result suggests that either
i) unlike other glycosyltransferases, this enzyme is not incorporated
into GEMS vesicles or ii) the reconstituted enzyme is inactive. Yet, it
is noteworthy that among the glycosyltransferases that we have
studied so far, the FucT-VII was the only protein exhibiting an
unusual diffuse intracellular distribution, which was clearly distin-
guishable from that of the Golgi marker α-mannosidase-II [42].
However, there was a good overlapping between the latter and the
other fucosyltransferase FucT-I [42]. Further work will be dedicated
to the functional reconstitution of α(1,3)-fucosyltransferase activityfrom cells engineered to express other enzymes including FucT-III,
FucT-VI or FucT-IX.
3.5. Analysis of oligosaccharides synthesized by GEMS
Thebiosynthetic pathways of core2-basedglycanshavebeenstudied
in the immune system [6] and successfully reproduced inCHO cells after
transfection with the C2GnT-I gene [20,43]. The wild-type CHO cells
synthesize the structure called core1, Galβ1-3GalNAc, which is further
acted-up by the sialyltransferases ST3Gal-I and ST6GalNAc-I to generate
a mixture of mono- and disialyl-core1 structures [44]. When C2GnT-I is
present, it converts the core1 into the core2 structure Galβ1-3
(GlcNAcβ1-6)GalNAc, by adding a β1,6-linked GlcNAc residue to
the GalNAc thereby starting a new branch that is further acted-up by
β(1,3/4)-galactosyltransferases and then byα(2,3)-sialyltransferases to
produce thedisialylatedhexasaccharideNeuAcα2-3Galβ1-3(NeuAcα2-
3Galβ1-3/4GlcNAcβ1-6)GalNAc [44]. As shown in Fig. 6, the O-glycans
produced bywild-type CHO cells (Fig. 6A) and CHO/C2GnT-I-EGFP cells
(Fig. 6B) were eluted within two major peaks (fractions 31–35 and
fractions 38–45) corresponding to the positions of oligosaccharide
standards 1 and 2 used to calibrate the Biogel P-4 column (attached
table to Fig. 6). This result is consistent with data from others [45] and
with our previous work [20] where we had identiﬁed the peak-1 as the
disialylated hexasaccharide NeuAcα2-3Galβ1-3(NeuAcα2-3Galβ1-3/
4GlcNAcβ1-6)GalNAc-OH and the peak-2 as mixture of mono- and
disialyl-core1 structure NeuAcα2-3Galβ1-3(NeuAcα2-6)GalNAc-OH.
To determine if using the GEMS material we could achieve the
synthesis of core2-based oligosaccharides like those synthesized by
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compared the recovered oligosaccharides to those synthesized by
[3H]glucosamine-labeled CHO/C2GnT-I-EGFP cells. For this purpose,
we set-up a three-step glycosylation experiment using a single batch of
a highly active GEMS preparation (400–450 10−6 U/mg) in one unique
buffer, that is the MES buffer pH 6.8 commonly used for the C2GnT-I
assay (see theﬂowchart of Fig. 5). Basically,we assumed that sinceGolgi
compartments might be interconnected, their chemical environment
including their buffering system, should not vary dramatically from a
compartment to another. Therefore, glycosyltransferases should put up
with one unique buffer, provided that speciﬁc ions are present in some
instances. Preliminary experiments have shown that the MES buffer
containing 10 mM MnCl2 is compatible with the galactosyl- and
sialyltransferase activities (data not shown). As described on Fig. 5,
theﬁrst reaction catalyzed by C2GnT-I was conducted in the presence of
UDP-[6-3H]GlcNAc to label oligosaccharides at an early stage thereby
allowing their detection throughout chromatographic steps. Then the
galactosyltransferase reaction started upon the introduction of 1 mM
UDP-Gal and10 mMMnCl2 for 30 min followedby the sialylation step in
the presence of 100 μM CMP-sialic acid for another half-hour (Fig. 6).
The resulting oligosacccharides were eluted from Sep-Pak columns,
subjected to β-elimination and applied to the Biogel P-4 column as
above. As shown in Fig. 6C, one major peak (fractions 29–36, peak-3) is
eluted at the same level as the peak-1 produced by CHO/C2GnT-I-EGFP
cells, although slightly larger than the latter. Three minor unidentiﬁed
peaks were also obtained that elute later than peak-3. This result
suggests that our three-step reaction produced an oligosaccharide with
similar chromatographic characteristics to the disialotetrasaccharide
producedby the parental CHO/C2GnT-I-EGFP cells.Moreover, this result
also discloses that, like the transfected C2GnT-I-EGFP, the endogenous
galactosyl- and sialyltransferases are recovered in GEMSwhere they are
functional.
After mild acidic treatment to remove sialic acid and another round
of Bio-Gel P-4 fractionation, the peak-3 is converted to a single peak
(peak-3c, fractions 48–52) that elutes at the same position as the
desialylated peak-1c (fractions 47–51), the latter being identiﬁed as
Galβ1-3(Galβ1-4GlcNAcβ1-6)GalNAc-OH [20,43] (see the table at-
tached to Fig. 6). Desialylation of the peak-1 generates two other
peaks corresponding to the unmodiﬁed original glycan (peak-1a) and
sialic acid (peak-1b). Sialic acid is not detected after acidic treatment of
the oligosaccharides produced by GEMS-mediated synthesis because in
those structures only GlcNAc residue carries the radioactive label. ThisFig. 5. Procedure ﬂowchart for sequential glycosylationresult clearly indicates that by using a single batch of the GEMS
preparation, we have succeeded in making 3 successive glycosylation
reactions in vitro, to create core2-based oligosaccharides that chro-
matographically behave like those produced by parental cells.
4. Discussion
In this study, we describe a reconstituted system enriched in several
Golgi glycosylransferases. This successful reconstitution was achieved
by combining the properties of thewheat germ lectin (WGA) and of the
detergent n-octylglucoside (OG). The choice ofWGAwas dictated by its
ability to interact with Golgi-resident proteins [16] and to crosslink
membrane glycoproteins in solution [17]. OG was chosen for its
properties of being easily removed from detergent extracts [18] and
for its limiteddelipidating effect on solubilizedmembrane proteins [30].
In this regard, preliminary experiments have shown that although other
detergents such as Tween 20, Triton X-100 or CHAPS could solubilize
active C2GnT-I to a certain extent, OGwas by far themost effectivewith
respect to vesicle formation and enzyme functionality (see Table 1). This
suggests that these detergents either were incompletely removed
during reconstitution or they caused enzymatic conformational changes
or were more delipidating reagents than OG. Moreover, the functional
reconstitution of glycosyltransferaseswas found to be highly dependent
on the way OG was excluded from cell extracts. Indeed, attempts to
reconstitute active glycosyltransferases through the removal of OG by
dialysis or gel ﬁltration, by adding an insoluble detergent scavenger like
polystyrene beads or by diluting the cell extracts below the critical
micellar concentration of the detergent, have met with little or no
success (data not shown).
In contrast, the OG exclusion by WGA-mediated precipitation of
glycoproteins produced a material composed of sealed membranes
containing sphingomyelin, phospholipids and cholesterol. Interest-
ingly, the GEMS (for«Glycosyltransferase-Enriched Membrane Sys-
tem»)-associated C2GnT-I exhibited about two-fold higher afﬁnity
toward the acceptor substrate than its soluble counterpart and about
11 times higher activity than in microsomal membranes (see Fig. 3E).
One likely explanation for the low microsome-associated C2GnT-I
activity could be that either glycosyltransferase-enriched compo-
nents of the Golgi are lost during puriﬁcation and/or the recovered
glycosyltransferases exhibit decreased activities. Others have
reported that Golgi fractions puriﬁed from microsomes of C2GnT-I-
expressing CHO cells exhibited a low core2-branching activityreactions catalyzed by the mean of GEMS material.
Fig. 6. Fractionation of O-glycans derived from CHO/C2GnT-I-EGFP or synthesized by the mean of GEMS. The [3H]glucosamine-labeled glycopeptides from CHO (A) or
CHO/C2GnT-I-EGFP (B) cell lysates were analyzed by liquid chromatography as described in Materials and methods. Brieﬂy, [3H]glucosamine-labeled glycopeptides were
subjected to alkaline borohydride treatment (β-elimination) and the released O-glycans were isolated by Sephadex G-50 gel ﬁltration and applied to a column of Bio-Gel
P-4 eluted with 0.1 M NH4HCO3. C) The [3H]glucosamine-labeled O-glycans recovered from Sep-Pak columns following GEMS-catalyzed sequential glycosylation
reactions were treated similarly and analyzed by liquid chromatography as above. D) After mild acidic treatment to remove sialic acid and another round of Bio-Gel P-4
fractionation, the peak-1 from (B) generates peaks 1a, 1b and 1c corresponding to structures presented on the table inserted in this ﬁgure. E) Similarly, after mild acidic
treatment the peak-3 from (C) is converted to the single peak-3c. Shown are representative results from two independent experiments.
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authors, this low activity could be due to vigorous and repeated
homogenization steps which may disrupt the fragile Golgi structure.
The Golgi integrity does not seem to be functionally relevant for
our system which requires detergent extraction and several homog-
enization and centrifugation steps. Instead, not only does the WGA
allow to recover a large part of membrane glycoproteins but above all,
leads to glycosyltransferases with catalytic domains turned outwards.
Although the process of WGA-mediated vesicle formation is not
immediately apparent, the extravesicular orientation of glycosyltrans-
ferases couldbe interpretedbya special arrangementbetween the lectinand membrane glycoproteins associated to lipids [46]. Indeed, these
complexesmay adopt anorientation such that transmembrane domains
interact with each other and with lipids on the one side while on the
opposite side, catalytic domains are assembled withWGA through their
carbohydrate moieties [47]. Thus, upon the dissociation of this complex
by the competing trisaccharide, onewould assume that transmembrane
domains become spontaneously incorporated into vesicles keeping
catalytic domains in an extravesicular orientation. Three lines of
evidence argue for such a topology: ﬁrstly, re-solubilizingGEMS vesicles
with OG does not result in an increase in C2GnT-I activity. Secondly,
most of theN-glycans linked to the catalytic domain of the reconstituted
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cleaved under native conditions. Thirdly, the use of a protein substrate
(asialofetuin) for sialyl- and fucosyltransferase activities, discloses an
enrichment factor between GEMS and detergent extracts in the
same range of magnitude (i.e., 4–5 times) as in the case of C2GnT-I
with its small acceptor substrate Galβ1-3GalNAc-O-p-nitrophenyl
(compare Figs. 3D and 4C).
By using this substrate we have succeeded in transforming it into
an oligosaccharide similar to the disialylated hexasaccharide
NeuAcα2-3Galβ1-3(NeuAcα2-3Galβ1-3/4GlcNAcβ1-6)GalNAc-OH
(see Fig. 6C and E). It is noteworthy thatwe achieved this synthesiswith
a single preparation of GEMS and without changing the tube or the
buffer; each reaction being triggered only when the desired sugar
nucleotide is added (see the ﬂowshart on Fig. 5). Thus, following the
C2GnT-I step, galactosylation and sialylation reactions were sequen-
tially initiated upon the addition of UDP-Gal and CMP-NeuAc,
respectively. Yet if CHO sialyltransferasesmainly catalyzeα(2,3)-linked
sialic acid on O-glycans [44] they express at least two types of
β-galactosyltransferases, the β(1,3)- and β(1,4)-galactosyltransferases
(β3GalT and β4GalT) [48]. Consequently, this combined galactosylation
could create a mixture of type-1 and type-2 lactosaminic structures on
the core2 branch. Nevertheless, Mitoma and co-workers have shown
that in CHO cells the core2 trisaccharide Galβ1-3(GlcNAcβ1-6)- GalNAc
is mainly acted-up by β4GalT rather than by β3GalT [44].
The mechanisms by which glycosylation is regulated in the Golgi
are not fully understood. It is suggested that the construction of
carbohydrate sequences relies on factors including the substrate
speciﬁcity of individual enzymes, their compartmentalization, their
competition toward acceptors and their interaction with sugar
nucleotide transporters [29]. Therefore, it seems to be extremely
difﬁcult to recreate such conditions outside the cell, all themore as the
idea of using intact Golgi has shown its limits [12]. In addition, Golgi
stacks are connected with other membrane systems through micro-
tubules [49] and therefore, there is a need for breaking-down the
cytoskeleton bymolecules such as nocodazole [50] prior to isolation of
Golgi components.
Given this remarkable complexity, the use of soluble recombinant
glycosyltransferases for synthesizing oligosaccharides or for glycosy-
lating recombinant proteins or cell surfaces provides an interesting
alternative [51]. However, one would have to produce these proteins
individually and in sufﬁcient quantities while solving the problems of
enzyme stability and buffer compatibilities. For example, to synthe-
size the core2-based disialylated hexasaccharide we have made using
GEMS, one would need to produce recombinant soluble forms of four
enzymes that are, the C2GnT-I, the β(1,4)-galactosyltransferase
(β4GalT) and two sialyltransferases ST3GalT-I and ST3GalT-IV. In
contrast, since CHO cells naturally express the three latter enzymes,
all is needed is transfection of cells with the C2GnT-I gene before
reconstitution of both native and recombinant membrane-anchored
and outward oriented Golgi glycosyltransferases. The integrated
nature of our system offers other beneﬁts that have not detailed
here. These include i) GEMS is sedimentable and thus it can be easily
separated from the soluble reagents by centrifugation and ii) GEMS-
associated glycosyltransferases are more stable at 37 °C than their
soluble counterparts. In fact, using the sialyltransferase ST6GalT-I
(α6ST) as a model and comparing it to the commercial enzyme
(Roche Molecular Biochemicals), we found that the latter lost more
than 75% of its activity after 1 h incubation at 37 °C, versus only 10–
15% for the GEMS-associated enzyme (Notel and El-Battari, personal
communication). These two properties may be exploited to re-use
GEMS material or to set-up a matrix for glycan synthesis such as the
so-called Golgi-on-a-chip system. This system is a digital microﬂuidic
chip, also called the artiﬁcial Golgi [52], which provides an interesting
alternative to chemical or chemo-enzymatical synthesis of natural
bioactive glycans. Nevertheless, this technique also requires puriﬁed
recombinant enzymes as well as expertise in physics, chemistry andbiology which may exist in few laboratories but is not widespread
at present. In contrast, our approach is easy to implement and requires
commercially available chemicals and materials commonly used in
most biochemistry laboratories.
In conclusion, we believe that this system lays the foundations
towards the synthesis of therapeutically relevant glycans including
sialyl-Lewis or MECA-79 antigens, either free or attached to aglycone
moieties. Furthermore, this reconstituted system can be easily
adapted for other reactions naturally occurring in the Golgi apparatus
for studies on the inﬂuence of lipids, pH or ions on glycosyltrans-
ferases functions. Some of these topics are currently under investi-
gation in our laboratory.
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